Funan Liu
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 11
- Genetics 20
- Virus-based gene therapy research 19
- Co-authors
- Zhenguo Cheng (14 shared papers)Zhenning Wang (10 shared papers)Hanwei Huang (14 shared papers)Huimian Xu (10 shared papers)Feng Li (4 shared papers)Mengchi Sun (8 shared papers)Yanshu Li (4 shared papers)Jin Sun (4 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Nano Today (5 papers)Nature Communications (2 papers)Cell Reports Medicine (2 papers)Chinese Chemical Letters (2 papers)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Funan Liu
49 papers receiving 1.3k citations
Funan Liu's Hit Papers
Peers
Comparison fields: 5 of 95
- Biotechnology 138
- Biomaterials 170
- Molecular Medicine 64
- Oncology 302
- Cancer Research 158
Countries citing papers authored by Funan Liu
This map shows the geographic impact of Funan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funan Liu more than expected).
Fields of papers citing papers by Funan Liu
This network shows the impact of papers produced by Funan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funan Liu. The network helps show where Funan Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Funan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 122 | |
| 2 | 2009 | 104 | |
| 3 | 2019 | 76 | |
| 4 | 2023 | 67 | |
| 5 | 2022 | 67 | |
| 6 | 2011 | 63 | |
| 7 | 2011 | 60 | |
| 8 | 2009 | 59 | |
| 9 | 2022 | 58 | |
| 10 | 2022 | 56 | |
| 11 | 2023 | 55 | |
| 12 | 2017 | 39 | |
| 13 | 2010 | 38 | |
| 14 | 2017 | 37 | |
| 15 | Coacervate vesicles assembled by liquid–liquid phase separation improve delivery of biopharmaceuticals Hit paper breakdown → | 2025 | 31 |
| 16 | 2017 | 28 | |
| 17 | 2015 | 27 | |
| 18 | 2018 | 24 | |
| 19 | 2022 | 23 | |
| 20 | 2018 | 20 |
About Funan Liu
Funan Liu is a scholar working on Molecular Biology, Genetics, Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (19 papers), Cancer Research and Treatments (14 papers), RNA Interference and Gene Delivery (11 papers), CAR-T cell therapy research (7 papers), Gastric Cancer Management and Outcomes (6 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Biotechnology (138 citations), Biomaterials (170 citations), Molecular Medicine (64 citations), Oncology (302 citations) and Cancer Research (158 citations). Funan Liu has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zhenguo Cheng, Zhenning Wang, Hanwei Huang, Huimian Xu, Feng Li, Mengchi Sun, Yanshu Li, Jin Sun, Zhonggui He and Chenggang Jiang. Their work appears in journals such as Journal of Clinical Oncology, Nano Today, Nature Communications, Cell Reports Medicine and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.